Aurelius Omlin
奥雷利乌斯·奥姆林
MD
Professor of Oncology; Head, Department of Oncology and Hematology肿瘤学教授；肿瘤与血液学科主任
👥Biography 个人简介
Aurelius Omlin leads oncology at Cantonal Hospital St. Gallen and is a recognized expert in mCRPC treatment sequencing, cabazitaxel chemotherapy, and PSMA-targeted theranostics. He has contributed to key trials optimizing treatment order and combinations in heavily pretreated prostate cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
mCRPC Treatment Sequencing and Theranostics
Contributed to clinical research defining optimal sequencing of cabazitaxel, AR pathway inhibitors, and PSMA radioligand therapy in mCRPC, improving outcomes for patients with advanced disease.
Representative Works 代表性著作
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer (CARD)
New England Journal of Medicine (2019)
Pivotal trial demonstrating cabazitaxel superiority over an alternative ARSI in mCRPC patients progressing after docetaxel and one ARSI, guiding treatment sequencing.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 奥雷利乌斯·奥姆林 的研究动态
Follow Aurelius Omlin's research updates
留下邮箱，当我们发布与 Aurelius Omlin（Cantonal Hospital St. Gallen）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment